OXIDANT MECHANISMS IN DRUG-INDUCED HEPATIC NECROSIS
药物引起的肝坏死的氧化机制
基本信息
- 批准号:3303424
- 负责人:
- 金额:$ 15.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-04-01 至 1994-03-31
- 项目状态:已结题
- 来源:
- 关键词:acetaminophen acetylation carbon tetrachloride carmustine cell death covalent bond deferoxamine drug adverse effect enzyme mechanism gas chromatography gas chromatography mass spectrometry glutathione peroxidase glutathione reductase hepatotoxin high performance liquid chromatography iron metabolism laboratory mouse laboratory rat lipids liver toxic disorder necrosis oxidation reduction reaction peroxidation physiologic stressor sulfates thiols
项目摘要
Many toxins kill cells by the metabolic generation of chemically reactive
intermediates that in turn produce alterations in cellular molecules,
compromising cell structure and function, leading to loss of viability.
Many chemical and biochemical changes are observed in such studies, not all
of which are involved critically in the initiation of damage.
Nevertheless, three major classes of tissue alteration are recognized:
alkylation, oxidation, and peroxidation. A difficulty in the study of
oxidant stress-induced hepatic necrosis has been the lack of an animal
model. Although the mechanistic involvement of reactive oxygen species has
been proposed for tissue damage initiated by a number of drugs and by
reflow following ischemia, much of what is known about the mechanisms
through which reactive oxygen species kill cells has been developed in
studies conducted in vitro, particularly in isolated or cultured rat
hepatocytes. We have found that diquat produces centribolular necrosis in
male Fischer-344 rats and several lines of evidence indicate that this
necrosis is mediated by the generation of reactive oxygen species. This
model has been studied further in an effort to understand the manner in
which reactive oxygen species and oxidant stress kills cells in vivo and to
develop quantitative criteria for distinguishing those examples of cell
death in vivo that may be mediated by oxidant mechanisms from those in
which the lethal effects ar expressed through other mechanisms.
Investigations of the diquat model of acute hepatic necrosis have
demonstrated some important differences from the hypotheses generated from
studies in vitro, particularly the role of shifts in cellular
thiol/disulfide ratios and the depletion of protein thiols. These studies
of the diquat model have revealed an apparently critical role of lipid
peroxidation in the expression of reactive oxygen injury in vivo, and that
the availability of chemically reactive chelates of iron appears to be an
essential determinant of peroxidation damage and cell death. The studies
described in this proposal are designed to apply chemically specific
methods of analysis to the investigation of the extent to which lipid
peroxidation is responsible for diquat-induced hepatic necrosis in vivo and
the role played by chemically reactive iron species in these processes.
These methods and approaches and the quantitative criteria developed in
these studies will be applied to a critical examination of the hypothesis
that oxidant stress mechanisms contribute to hepatic necrosis initiated by
acetaminophen an by carbon tetrachloride. Because the latter two agents
are such important model hepatotoxins, the proposed studies are directed at
issues that are fundamental to our understanding of the mechanisms of cell
death in vivo.
许多毒素通过代谢产生化学活性物质来杀死细胞。
这些中间体反过来又会改变细胞分子,
损害细胞结构和功能,导致活力丧失。
在这些研究中观察到许多化学和生物化学变化,
其中,关键的一点是引发损害。
然而,三个主要类别的组织改变是公认的:
烷基化、氧化和过氧化。 研究中的一个难点
氧化应激诱导的肝坏死一直缺乏动物
模型 尽管活性氧的参与机制
被提议用于由许多药物引起的组织损伤,
缺血后的再流,许多已知的机制,
通过该反应性氧物质杀死细胞,
在体外进行的研究,特别是在分离或培养的大鼠中进行的研究
肝细胞 我们已经发现敌草快在小鼠中产生中心球坏死。
雄性Fischer-344大鼠和一些证据表明,
坏死是由活性氧物质的产生介导的。 这
模型已被进一步研究,以了解在
其中活性氧物质和氧化应激在体内杀死细胞,
开发用于区分这些细胞实例的定量标准
体内死亡,可能是由氧化剂机制介导的,
其致死作用是通过其他机制表达的。
急性肝坏死敌草快模型的研究已经
证明了一些重要的差异,从产生的假设,
体外研究,特别是细胞内转移的作用,
巯基/二硫化物比率和蛋白质巯基的消耗。 这些研究
的敌草快模型揭示了一个明显的关键作用,脂质
过氧化反应在体内表达活性氧损伤,
铁的化学反应性螯合物的可用性似乎是
过氧化损伤和细胞死亡的基本决定因素。 研究
本提案中所述的化学物质,
分析方法,以调查在何种程度上,脂质
过氧化作用是敌百虫诱导的体内肝坏死的原因,
在这些过程中,化学反应性铁物质所起的作用。
这些方法和办法以及在1998年制定的定量标准,
这些研究将被应用于对假设的批判性检验
氧化应激机制导致肝坏死,
对乙酰氨基酚和四氯化碳。 因为后两个探员
是如此重要的模型肝毒素,拟议的研究是针对
这些问题对于我们理解细胞的机制至关重要,
体内死亡
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES Vincent SMITH其他文献
CHARLES Vincent SMITH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES Vincent SMITH', 18)}}的其他基金
Glucose utilization and metabolism during cardiac surgery
心脏手术期间的葡萄糖利用和代谢
- 批准号:
6974896 - 财政年份:2004
- 资助金额:
$ 15.59万 - 项目类别:
Alzheimer's Disease Genetics Initiative: The Multiplex Family Study
阿尔茨海默病遗传学计划:多重家庭研究
- 批准号:
7043697 - 财政年份:2004
- 资助金额:
$ 15.59万 - 项目类别:
Oxidant Mechanisms in Drug-Induced Hepatic Necrosis
药物性肝坏死中的氧化机制
- 批准号:
6734228 - 财政年份:1998
- 资助金额:
$ 15.59万 - 项目类别:
Oxidant Mechanisms in Drug-Induced Hepatic Necrosis
药物性肝坏死中的氧化机制
- 批准号:
6858815 - 财政年份:1998
- 资助金额:
$ 15.59万 - 项目类别:
Oxidant Mechanisms in Drug-Induced Hepatic Necrosis
药物性肝坏死中的氧化机制
- 批准号:
6630266 - 财政年份:1998
- 资助金额:
$ 15.59万 - 项目类别:
Oxidant Mechanisms in Drug-Induced Hepatic Necrosis
药物性肝坏死中的氧化机制
- 批准号:
7235959 - 财政年份:1998
- 资助金额:
$ 15.59万 - 项目类别:
相似海外基金
Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
- 批准号:
EP/Y000331/1 - 财政年份:2023
- 资助金额:
$ 15.59万 - 项目类别:
Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
- 批准号:
10677295 - 财政年份:2023
- 资助金额:
$ 15.59万 - 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
- 批准号:
10635599 - 财政年份:2023
- 资助金额:
$ 15.59万 - 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
- 批准号:
10752320 - 财政年份:2023
- 资助金额:
$ 15.59万 - 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
- 批准号:
478927 - 财政年份:2023
- 资助金额:
$ 15.59万 - 项目类别:
Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
- 批准号:
10855703 - 财政年份:2023
- 资助金额:
$ 15.59万 - 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
- 批准号:
10654210 - 财政年份:2023
- 资助金额:
$ 15.59万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 15.59万 - 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
- 批准号:
10667952 - 财政年份:2023
- 资助金额:
$ 15.59万 - 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
- 批准号:
10726986 - 财政年份:2023
- 资助金额:
$ 15.59万 - 项目类别:














{{item.name}}会员




